カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 1,201 | 1,212 | 1,191 | 1,212 | +2 | +0.2% | 3,400 |
| 2024/04/25 | 1,225 | 1,227 | 1,203 | 1,210 | -1 | -0.1% | 16,700 |
| 2024/04/24 | 1,202 | 1,211 | 1,202 | 1,211 | +7 | +0.6% | 1,900 |
| 2024/04/23 | 1,200 | 1,219 | 1,200 | 1,204 | +12 | +1% | 4,100 |
| 2024/04/22 | 1,190 | 1,205 | 1,190 | 1,192 | +7 | +0.6% | 2,200 |
| 2024/04/19 | 1,202 | 1,206 | 1,170 | 1,185 | -17 | -1.4% | 7,500 |
| 2024/04/18 | 1,209 | 1,209 | 1,197 | 1,202 | -9 | -0.7% | 800 |
| 2024/04/17 | 1,204 | 1,213 | 1,181 | 1,211 | +2 | +0.2% | 3,300 |
| 2024/04/16 | 1,210 | 1,229 | 1,205 | 1,209 | -1 | -0.1% | 2,000 |
| 2024/04/15 | 1,218 | 1,229 | 1,210 | 1,210 | -8 | -0.7% | 1,600 |
| 2024/04/12 | 1,228 | 1,228 | 1,200 | 1,218 | -2 | -0.2% | 6,300 |
| 2024/04/11 | 1,214 | 1,228 | 1,208 | 1,220 | ±0 | ±0% | 2,100 |
| 2024/04/10 | 1,231 | 1,232 | 1,218 | 1,220 | -11 | -0.9% | 3,100 |
| 2024/04/09 | 1,217 | 1,240 | 1,210 | 1,231 | +1 | +0.1% | 3,200 |
| 2024/04/08 | 1,220 | 1,230 | 1,204 | 1,230 | +10 | +0.8% | 6,900 |
| 2024/04/05 | 1,219 | 1,220 | 1,193 | 1,220 | ±0 | ±0% | 6,400 |
| 2024/04/04 | 1,190 | 1,220 | 1,190 | 1,220 | +31 | +2.6% | 6,000 |
| 2024/04/03 | 1,186 | 1,194 | 1,161 | 1,189 | +1 | +0.1% | 4,100 |
| 2024/04/02 | 1,185 | 1,192 | 1,173 | 1,188 | +2 | +0.2% | 2,300 |
| 2024/04/01 | 1,197 | 1,198 | 1,160 | 1,186 | -11 | -0.9% | 9,300 |
| 2024/03/29 | 1,202 | 1,217 | 1,191 | 1,197 | -12 | -1% | 4,700 |
| 2024/03/28 | 1,220 | 1,221 | 1,181 | 1,209 | -13 | -1.1% | 5,000 |
| 2024/03/27 | 1,238 | 1,238 | 1,220 | 1,222 | -13 | -1.1% | 4,100 |
| 2024/03/26 | 1,249 | 1,249 | 1,205 | 1,235 | -3 | -0.2% | 8,700 |
| 2024/03/25 | 1,218 | 1,289 | 1,213 | 1,238 | +18 | +1.5% | 69,600 |
| 2024/03/22 | 1,213 | 1,220 | 1,194 | 1,220 | +10 | +0.8% | 11,300 |
| 2024/03/21 | 1,206 | 1,219 | 1,183 | 1,210 | +5 | +0.4% | 4,700 |
| 2024/03/19 | 1,219 | 1,219 | 1,176 | 1,205 | -3 | -0.2% | 4,500 |
| 2024/03/18 | 1,198 | 1,231 | 1,198 | 1,208 | -2 | -0.2% | 5,900 |
| 2024/03/15 | 1,174 | 1,212 | 1,173 | 1,210 | +32 | +2.7% | 12,200 |
| 2024/03/14 | 1,173 | 1,178 | 1,173 | 1,178 | ±0 | ±0% | 500 |
| 2024/03/13 | 1,173 | 1,183 | 1,173 | 1,178 | +2 | +0.2% | 3,300 |
| 2024/03/12 | 1,184 | 1,184 | 1,173 | 1,176 | -4 | -0.3% | 1,700 |
| 2024/03/11 | 1,182 | 1,193 | 1,172 | 1,180 | -14 | -1.2% | 3,800 |
| 2024/03/08 | 1,186 | 1,194 | 1,177 | 1,194 | +6 | +0.5% | 2,600 |
| 2024/03/07 | 1,198 | 1,198 | 1,181 | 1,188 | -6 | -0.5% | 5,000 |
| 2024/03/06 | 1,166 | 1,195 | 1,166 | 1,194 | +22 | +1.9% | 9,900 |
| 2024/03/05 | 1,165 | 1,172 | 1,161 | 1,172 | +9 | +0.8% | 1,300 |
| 2024/03/04 | 1,175 | 1,175 | 1,160 | 1,163 | ±0 | ±0% | 7,000 |
| 2024/03/01 | 1,152 | 1,176 | 1,150 | 1,163 | +12 | +1% | 6,500 |
| 2024/02/29 | 1,166 | 1,166 | 1,151 | 1,151 | -1 | -0.1% | 2,600 |
| 2024/02/28 | 1,149 | 1,153 | 1,146 | 1,152 | +2 | +0.2% | 1,500 |
| 2024/02/27 | 1,155 | 1,155 | 1,146 | 1,150 | +1 | +0.1% | 5,100 |
| 2024/02/26 | 1,156 | 1,156 | 1,145 | 1,149 | -4 | -0.3% | 5,000 |
| 2024/02/22 | 1,150 | 1,155 | 1,144 | 1,153 | +11 | +1% | 5,800 |
| 2024/02/21 | 1,146 | 1,150 | 1,138 | 1,142 | -4 | -0.3% | 2,200 |
| 2024/02/20 | 1,144 | 1,155 | 1,144 | 1,146 | +2 | +0.2% | 2,400 |
| 2024/02/19 | 1,133 | 1,149 | 1,133 | 1,144 | +12 | +1.1% | 8,300 |
| 2024/02/16 | 1,128 | 1,132 | 1,118 | 1,132 | +10 | +0.9% | 5,100 |
| 2024/02/15 | 1,146 | 1,147 | 1,118 | 1,122 | -24 | -2.1% | 20,900 |
1～
50
件表示中 / 3445件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 121,200円 | +5.6% | -0.4% | 2.64% | 8.96倍 | 0.86倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＤＥＬＴＡ－Ｐ | 77,800円 | - | - | 0.00% | - | 15.97倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| サイフューズ | 70,500円 | +891.8% | - | 0.00% | - | 1.74倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| キッズバイオ | 13,600円 | -4.5% | - | 0.00% | - | 5.94倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ソレイジア | 2,600円 | +102.6% | - | 0.00% | - | 2.52倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
市場注目の銘柄
チャート関連のコラム
